acute leukemia, aggressive lymphoma, bronchial carcinoma, pancreatic carcinoma and colon carcinoma (advanced stage), multiple myeloma and malignant plasma cell neoplasms, metastasized malignant neoplasm of breast, metastasized malignant neoplasm of ovary, metastasized malignant neoplasm of cervix uteri, metastasized malignant neoplasm of corpus uteri, malignant neoplasm of stomach, malignant neoplasm of esophagus, metastasized malignant neoplasms of lip, oral cavity, and pharynx, metastasize
Conditions
Interventions
Group 1: Intervention Group with 150 patients: Support through 12 structured interviews and specific measures (if necessary) within 1 year
Group 2: Controll group with 200 patients. No Support from th
Sponsors
pronova BKK (Konsortialführung)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: acute leukemia, aggressive lymphoma, bronchial carcinoma, pancreatic carcinoma, colon carcinoma (advanced stage), multiple myeloma and malignant plasma cell neoplasms, metastasized malignant neoplasm of breast, metastasized malignant neoplasm of ovary, metastasized malignant neoplasm of cervix uteri, metastasized malignant neoplasm of corpus uteri, malignant neoplasm of stomach, malignant neoplasm of esophagus, metastasized malignant neoplasms of lip, oral cavity, and pharynx, metastasized malignant neoplasm of prostate, metastasized malignant neoplasm of thyroid gland, metastasized melanoma and other malignant neoplasms of skin
Exclusion criteria
Exclusion criteria: advanced dementia, acute addiction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary aim of this study is to determine changes in the doctor-patient communication, the health literacy and the quality of life in the participating patients. The effects will be measured by repeated interviews within one year. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary aim is to evaluate the association between health literacy, participation, improved communication and quality of life. In addition, objective outcomes will be measured with secondary data (statutory health insurance) to analyse the effects caused by participants in the program OSCAR (e.g. health care utilization, costs) in comparison to non-participants. | — |
Countries
Germany
Contacts
Public ContactJohann Frick
Institut für Medizinische Soziologie und Rehabilitationswissenschaft
Outcome results
None listed